National Institute of Health Research Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, UK; Neurosurgery Division, University Teaching Hospital, Lusaka, Zambia.
National Institute of Health Research Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, UK.
Lancet Neurol. 2022 May;21(5):438-449. doi: 10.1016/S1474-4422(22)00037-0. Epub 2022 Mar 16.
Traumatic brain injury (TBI) is increasingly recognised as being responsible for a substantial proportion of the global burden of disease. Neurosurgical interventions are an important aspect of care for patients with TBI, but there is little epidemiological data available on this patient population. We aimed to characterise differences in casemix, management, and mortality of patients receiving emergency neurosurgery for TBI across different levels of human development.
We did a prospective observational cohort study of consecutive patients with TBI undergoing emergency neurosurgery, in a convenience sample of hospitals identified by open invitation, through international and regional scientific societies and meetings, individual contacts, and social media. Patients receiving emergency neurosurgery for TBI in each hospital's 30-day study period were all eligible for inclusion, with the exception of patients undergoing insertion of an intracranial pressure monitor only, ventriculostomy placement only, or a procedure for drainage of a chronic subdural haematoma. The primary outcome was mortality at 14 days postoperatively (or last point of observation if the patient was discharged before this time point). Countries were stratified according to their Human Development Index (HDI)-a composite of life expectancy, education, and income measures-into very high HDI, high HDI, medium HDI, and low HDI tiers. Mixed effects logistic regression was used to examine the effect of HDI on mortality while accounting for and quantifying between-hospital and between-country variation.
Our study included 1635 records from 159 hospitals in 57 countries, collected between Nov 1, 2018, and Jan 31, 2020. 328 (20%) records were from countries in the very high HDI tier, 539 (33%) from countries in the high HDI tier, 614 (38%) from countries in the medium HDI tier, and 154 (9%) from countries in the low HDI tier. The median age was 35 years (IQR 24-51), with the oldest patients in the very high HDI tier (median 54 years, IQR 34-69) and the youngest in the low HDI tier (median 28 years, IQR 20-38). The most common procedures were elevation of a depressed skull fracture in the low HDI tier (69 [45%]), evacuation of a supratentorial extradural haematoma in the medium HDI tier (189 [31%]) and high HDI tier (173 [32%]), and evacuation of a supratentorial acute subdural haematoma in the very high HDI tier (155 [47%]). Median time from injury to surgery was 13 h (IQR 6-32). Overall mortality was 18% (299 of 1635). After adjustment for casemix, the odds of mortality were greater in the medium HDI tier (odds ratio [OR] 2·84, 95% CI 1·55-5·2) and high HDI tier (2·26, 1·23-4·15), but not the low HDI tier (1·66, 0·61-4·46), relative to the very high HDI tier. There was significant between-hospital variation in mortality (median OR 2·04, 95% CI 1·17-2·49).
Patients receiving emergency neurosurgery for TBI differed considerably in their admission characteristics and management across human development settings. Level of human development was associated with mortality. Substantial opportunities to improve care globally were identified, including reducing delays to surgery. Between-hospital variation in mortality suggests changes at an institutional level could influence outcome and comparative effectiveness research could identify best practices.
National Institute for Health Research Global Health Research Group.
创伤性脑损伤(TBI)越来越被认为是导致全球疾病负担的一个重要因素。神经外科干预是 TBI 患者治疗的一个重要方面,但关于这一患者群体的流行病学数据很少。我们的目的是描述在不同人类发展水平下,接受 TBI 紧急神经外科治疗的患者在病例组合、管理和死亡率方面的差异。
我们对接受 TBI 紧急神经外科治疗的连续患者进行了一项前瞻性观察性队列研究,研究对象是通过国际和地区科学协会和会议、个人联系和社交媒体,从公开邀请的医院中随机抽取的便利样本。在每家医院的 30 天研究期间,所有接受 TBI 紧急神经外科治疗的患者都有资格入选,但以下情况除外:仅插入颅内压监测器、仅放置脑室引流管或进行慢性硬脑膜下血肿引流的患者。主要结局是术后 14 天(或如果患者在此时间点前出院,则为最后一次观察点)的死亡率。根据人类发展指数(HDI)-预期寿命、教育和收入指标的综合指标-将国家分为非常高的 HDI、高的 HDI、中高的 HDI 和低的 HDI 四个层次。使用混合效应逻辑回归来检查 HDI 对死亡率的影响,同时考虑和量化医院间和国家间的差异。
我们的研究包括来自 57 个国家的 159 家医院的 1635 份记录,收集时间为 2018 年 11 月 1 日至 2020 年 1 月 31 日。328 份记录来自非常高的 HDI 国家,539 份记录来自高的 HDI 国家,614 份记录来自中高的 HDI 国家,154 份记录来自低的 HDI 国家。患者的中位年龄为 35 岁(IQR 24-51),最年长的患者在非常高的 HDI 国家(中位数 54 岁,IQR 34-69),最年轻的患者在低的 HDI 国家(中位数 28 岁,IQR 20-38)。最常见的手术是在低的 HDI 国家进行凹陷性颅骨骨折抬高术(69 [45%]),在中高的 HDI 国家和高的 HDI 国家进行额部硬膜外血肿清除术(189 [31%]和 173 [32%]),在非常高的 HDI 国家进行额部急性硬膜下血肿清除术(155 [47%])。从受伤到手术的中位时间为 13 小时(IQR 6-32)。总死亡率为 18%(299/1635)。在调整病例组合后,中高的 HDI 国家(比值比[OR] 2.84,95%CI 1.55-5.2)和高的 HDI 国家(2.26,1.23-4.15)的死亡率更高,但低的 HDI 国家(1.66,0.61-4.46)则没有(与非常高的 HDI 国家相比)。死亡率存在显著的医院间差异(中位数 OR 2.04,95%CI 1.17-2.49)。
接受 TBI 紧急神经外科治疗的患者在入院特征和治疗管理方面在人类发展环境方面有很大差异。人类发展水平与死亡率相关。在全球范围内,有很大的机会可以改善治疗,包括减少手术延迟。死亡率的医院间差异表明,机构层面的变化可能会影响结果,比较有效性研究可以确定最佳实践。
国家卫生研究院全球健康研究组。